Modest improvement in survival of patients with refractory anemia with excess blasts in the hypomethylating agents era in the United States

MeSH terms

• Anemia, Refractory, with Excess of Blasts / drug therapy*
• Anemia, Refractory, with Excess of Blasts / epidemiology
• Anemia, Refractory, with Excess of Blasts / genetics
• Anemia, Refractory, with Excess of Blasts / mortality*
• Antineoplastic Agents / pharmacology
• Antineoplastic Agents / therapeutic use*
• DNA Methylation / drug effects*
• Female
• Humans
• Male
• Molecular Targeted Therapy
• SEER Program
• Survival Rate
• Treatment Outcome
• United States / epidemiology